Over a quarter million germline mutations catalogued HGMD now contains 256,070 germline mutations As of March 29, 2019, HGMD contains…

As more research emerges surrounding the standardization of tumor mutational burden (TMB) assessment, a universal definition of “high TMB” across…

Sean Scott, QIAGEN’s Chief Business Officer and Vice President of Business Development for Clinical Genomics and Bioinformatics, discusses the N-of-One…

QIAGEN acquires N-of-One, expanding its clinical bioinformatics capabilities in molecular oncology decision support We are excited to announce our acquisition N-of-One,…

HGMD® Professional version 2018.4 contains a total of 248,700 mutations entries—that’s 8,431 more mutation entries than the previous release! Unlike other…

Introducing a novel myeloid gene panel for the GeneReader NGS System with integrated variant analysis, interpretation and reporting from QIAGEN…

Fall is in full swing, and 2019 is fast approaching! Here’s a look at some of the top bioinformatics-adjacent stories…

HGMD® Professional version 2018.3 contains a total of 240,269 mutations entries—that’s 7,826 more mutation entries than the previous release! Human…

As the number of genomes sequenced each day continues to skyrocket and healthcare professionals increasingly rely on genetic information to…

The industry’s top contenders went head-to-head in this year’s Battle of the Bioinformatics Pipelines at AMP Europe 2018. Variants were…

Health care providers need access to up-to-date and clinically-actionable clinical decision support tools in order to adopt precision medicine. But, how…

The latest HGMD® Professional release is now available! Version 2018.2 contains a total of 232,443 mutation entries—that’s 7,801 more mutation…